创伤性脑损伤患者呼吸机相关性肺炎的发生率、危险因素与结局:一项Meta分析
该Meta分析检索PubMed、EMBASE、Cochrane Library和Web of Science数据库至2018年5月,评估创伤性脑损伤患者呼吸机相关性肺炎的发生率、危险因素和结局。结果显示VAP发生率为36%(95%CI 31-41%)。吸烟、气管切开、入院输血、巴比妥类药物输注、损伤严重度评分和头部简明损伤定级与VAP发生相关。发生VAP时机械通气时间、ICU住院时间和总住院时间显著增加,但VAP与死亡率增加无关(OR 1.28;95%CI 0.74-2.21)。
要点
- 创伤性脑损伤患者VAP发生率为36%(95%CI 31-41%)。
- 气管切开与VAP发生相关(OR 9.55;95%CI 3.24-28.17)。
- 损伤严重度评分(OR 4.65;95%CI 1.96-7.34)和头部简明损伤定级(OR 2.99;95%CI 1.66-5.37)与VAP发生相关。
- 发生VAP时机械通气时间延长(OR 5.45;95%CI 3.78-7.12)、ICU住院时间延长(OR 6.85;95%CI 4.90-8.79)、总住院时间延长(OR 10.92;95%CI 9.12-12.72)。
- VAP与死亡率增加无关(OR 1.28;95%CI 0.74-2.21)。
适用人群与场景
- 创伤性脑损伤患者。
研究设计与关键结果
- 研究类型为Meta分析,检索PubMed、EMBASE、Cochrane Library和Web of Science数据库至2018年5月,纳入报告创伤性脑损伤患者VAP发生率、危险因素和结局的研究。
- VAP发生率为36%(95%CI 31-41%)。
- 吸烟与VAP发生相关(OR 2.13;95%CI 1.16-3.92)。
- 气管切开与VAP发生相关(OR 9.55;95%CI 3.24-28.17)。
- 入院输血与VAP发生相关(OR 2.54;95%CI 1.24-5.18)。
- 巴比妥类药物输注与VAP发生相关(OR 3.52;95%CI 1.68-7.40)。
- 损伤严重度评分与VAP发生相关(OR 4.65;95%CI 1.96-7.34)。
- 头部简明损伤定级与VAP发生相关(OR 2.99;95%CI 1.66-5.37)。
证据类型、等级与局限
- 证据类型:Meta分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Ventilator-associated pneumonia (VAP) is one of the most severe complications in patients with traumatic brain injury (TBI) and is considered a risk factor for poor outcomes. However, the incidence of VAP among patients with TBI reported in studies varies widely. What is more, the risk factors and outcomes of VAP are controversial. This study estimates the incidence, risk factors, and outcomes of VAP in patients with TBI and provides evidence for prevention and treatment. PubMed, EMBASE, Cochrane Library, and Web of Science databases were searched from the earliest records to May 2018. Data involving the incidence, risk factors, and outcomes were extracted for meta-analysis. The results showed that the incidence of VAP was 36% (95% confidence interval (CI) 31-41%); risk factors analyses showed that smoking [odds ratio (OR) 2.13; 95% CI 1.16-3.92], tracheostomy (OR 9.55; 95% CI 3.24-28.17), blood transfusion on admission (OR 2.54; 95% CI 1.24-5.18), barbiturate infusion (OR 3.52; 95% CI 1.68-7.40), injury severity score (OR 4.65; 95% CI 1.96-7.34), and head abbreviated injury scale (OR 2.99; 95% CI 1.66-5.37) were related to the occurrence of VAP. When patients developed VAP, mechanical ventilation time (OR 5.45; 95% CI 3.78-7.12), ICU length of stay (OR 6.85; 95% CI 4.90-8.79), and hospital length of stay (OR 10.92; 95% CI 9.12-12.72) were significantly increased. However, VAP was not associated with an increased risk of mortality (OR 1.28; 95% CI 0.74-2.21). VAP is common in patients with TBI. It is affected by a series of factors and has a poor prognosis.
参考来源
- Li Y, Liu C, Xiao W, et al. Incidence, Risk Factors, and Outcomes of Ventilator-Associated Pneumonia in Traumatic Brain Injury: A Meta-analysis. Neurocrit Care. 2020. PMID: 31300956. doi:10.1007/s12028-019-00773-w
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。